In the 1950s, C-reactive protein (CRP) was first identified as an inflammatory biomarker for acute myocardial infarction (AMI), and decades later, it was also shown to be associated with cardiac hypertrophy and failure (3–7). This evidence concerns the gene CRP and acute myocardial infarction.